Because no one should face myositis alone.Give Now!

New Hope for Those with Myositis

By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…

Continue Reading

TMA Funding Supports Early Career Researcher

By Begum Horuluoglu, PhD Thanks to the generous support of The Myositis Association (TMA), I have been able to pursue groundbreaking research into the immunological mechanisms underlying idiopathic inflammatory myopathies,…

Continue Reading

De-stressing the Holidays

By Dorothy Vetrano The holiday season is upon us! It’s a time to celebrate with family and friends, enjoy home-cooked foods, and give thanks for all the blessings in our…

Continue Reading